Medication use during pregnancy among women with congenital physical disabilities.
Medication use during pregnancy among women with congenital physical disabilities.
复制标题
DOI:
10.1002/bdr2.2048
复制
发表时间:
2022-08-15
影响因子:
2.1
通讯作者:
Werler, Martha M.
中科院分区:
文献类型:
--
作者:
Garcia, Michelle Huezo;Petersen, Julie M.;Parker, Samantha E.;Rubenstein, Eric;Werler, Martha M.
Medication use during pregnancy is common, with up to 90% of pregnant women taking at least one medication. Women with congenital physical disabilities often report co-occurring conditions during pregnancy that may warrant pharmaceutical treatment, however, research is limited. We aim to describe medication use during pregnancy including: pain, psychotropic, and antibacterial medication, among women with and without congenital physical disabilities. We used data from the Slone Birth Defects Study (1976–2015), a case–control study that collected information on pre-pregnancy health conditions and exposures among participating mothers. Women with congenital physical disabilities (n = 132) included women with spina bifida, cerebral palsy, muscular dystrophy, limb deficiencies, and other skeletal/connective tissue conditions and were matched by interview year and study site to women without congenital physical disabilities (n = 528). Proportions and difference in proportions for each medication were compared between groups. Simple proportions were also calculated for duration and multiple medication use variables. Women with congenital physical disabilities more frequently reported use of pain (acetaminophen and opioids), psychotropic (antidepressants), and antibacterial medications during pregnancy. Women with congenital physical disabilities used pain and psychotropic medications for longer, frequent durations, and more frequently reported haven taken multiple medications during pregnancy. Women with congenital physical disabilities report higher medication use during pregnancy compared to women without physical disabilities. Patterns may be attributable to co-occurring conditions or increased risk of pregnancy complications in this population. Further research is needed to describe the patterns of medication use for clinical decisions regarding treatment of pregnant women with disabilities.
登录
查看更多内容
影响因子:
9.8
作者:
Mitchell AA;Gilboa SM;Werler MM;Kelley KE;Louik C;Hernández-Díaz S;National Birth Defects Prevention Study
通讯作者:
National Birth Defects Prevention Study
DOI:
10.1016/j.apmr.2005.11.003
发表时间:
2006-03-01
影响因子:
4.3
作者:
Nosek, MA;Hughes, RB;Morgan, R
通讯作者:
Morgan, R
DOI:
10.1001/archpediatrics.2009.188
发表时间:
2009-11-01
影响因子:
--
作者:
Crider, Krista S.;Cleves, Mario A.;Hu, Dale J.
通讯作者:
Hu, Dale J.
影响因子:
3.6
作者:
Bellin, Melissa H.;Zabel, T. Andrew;Braun, Patricia
通讯作者:
Braun, Patricia
影响因子:
--
作者:
Banhidy, Ferenc;Acs, Nandor;Czeizel, Andrew E.
通讯作者:
Czeizel, Andrew E.